UM-HMC-3A Cells
USD$700.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | UM-HMC-3A is a human mucoepidermoid carcinoma cell line established from the local recurrence of a salivary gland tumor in an adult patient, several years after surgical resection of the primary lesion. It is part of a matched pair of cell lines (UM-HMC-3A and UM-HMC-3B) derived from the same individual, representing distinct stages of disease progression, namely local recurrence and lymph node metastasis. UM-HMC-3A cells display a stable epithelial-like morphology in vitro, forming cobblestone-like monolayers and maintaining consistent growth characteristics over extended culture, with successful propagation reported beyond 100 passages. Short tandem repeat profiling confirms their origin from the patient tumor and excludes cross-contamination, supporting their reliability as a model system. UM-HMC-3A demonstrates tumorigenic capacity in vivo, forming xenograft tumors when implanted into immunodeficient mice. These xenografts recapitulate key histopathological features of the original patient tumor, including the presence of both epidermoid-like and mucin-producing cell populations. Periodic Acid–Schiff (PAS) staining reveals mucopolysaccharide production comparable to human tumors, indicating preserved functional differentiation. Compared to its metastatic counterpart (UM-HMC-3B), UM-HMC-3A typically shows slower tumor formation and less consistent initial engraftment, reflecting biological differences associated with local recurrence versus metastatic progression. UM-HMC-3A provides a valuable, well-characterized model for investigating tumor recurrence, epithelial differentiation, and therapeutic responses in salivary gland mucoepidermoid carcinoma. |
|---|---|
| Organism | Human |
| Tissue | Oral cavity, hard palate |
| Disease | Hard palate mucoepidermoid carcinoma |
| Synonyms | University of Michigan-Human Mucoepidermoid Carcinoma-3A |
Characteristics
| Age | 73 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Growth properties | Adherent |
Regulatory Data
| Citation | UM-HMC-3A (Cytion catalog number 305717) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_Y471 |
Biomolecular Data
| Mutational profile | Mutation: Gene fusion, CRTC1 + HGNC, MAML2, Name(s)=CRTC1-MAML2, MECT1-MAML2. |
|---|
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305717-091225 | Certificate of Analysis | 15. Jan. 2026 | 305717 |
-
Related products
Related products